PMID- 12721791 OWN - NLM STAT- MEDLINE DCOM- 20040224 LR - 20200228 IS - 1434-5161 (Print) IS - 1434-5161 (Linking) VI - 48 IP - 6 DP - 2003 TI - GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines. PG - 331-335 LID - 10.1007/s10038-003-0026-2 [doi] AB - Comparative genomic hybridization (CGH) analyses have detected gains of copy number on 13q, especially at 13q31-q32, in cell lines and primary cases of various types of lymphoma. Since amplification of chromosomal DNA is one of the mechanisms that can activate tumor-associated genes, and because 13q amplification had been reported in various other types of tumors as well, we attempted to define by fluorescence in situ hybridization (FISH) a common region at 13q31-q32 in which to explore genes that might be targets for the amplification events. Although the commonly amplified region we defined was relatively large (approximately 4 Mb), only one true gene, GPC5, was found there. GPC5 was over-expressed in lymphoma cell lines that had shown amplification, in comparison with those that had not. Our findings suggest that GPC5 is a likely target for amplification, and that over-expression of this gene may contribute to development and/or progression of lymphomas and other tumors. FAU - Yu, Wei AU - Yu W AD - Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. FAU - Inoue, Jun AU - Inoue J AD - Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. AD - Theranostics Research Center (TRC), Otsuka Pharmaceutical Co., 463-10 Kagasuno Kawauchi-cho, Tokushima 771-0192, Japan. FAU - Imoto, Issei AU - Imoto I AD - Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. AD - Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation (JST), 4-1-8 Honmachi, Kawaguchi 332-0012, Japan. FAU - Matsuo, Yoshinobu AU - Matsuo Y AD - Fujisaki Cell Center, Hayashibara Biochemical Laboratories, 675-1 Fujisaki, Okayama 702-8006, Japan. FAU - Karpas, Abraham AU - Karpas A AD - Department of Hematology, University of Cambridge Clinical School, MRC Centre, Hills Road, Cambridge, CB2 2QH, United Kingdom. FAU - Inazawa, Johji AU - Inazawa J AD - Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. johinaz.cgen@mri.tmd.ac.jp. AD - Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation (JST), 4-1-8 Honmachi, Kawaguchi 332-0012, Japan. johinaz.cgen@mri.tmd.ac.jp. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20030429 PL - England TA - J Hum Genet JT - Journal of human genetics JID - 9808008 RN - 0 (DNA, Neoplasm) RN - 0 (Extracellular Matrix Proteins) RN - 0 (GPC5 protein, human) RN - 0 (Glypicans) RN - 0 (Heparan Sulfate Proteoglycans) RN - 0 (RNA, Messenger) SB - IM MH - Cell Line, Tumor MH - Chromosomes, Artificial, Bacterial/genetics MH - Chromosomes, Human, Pair 13/*genetics MH - *DNA, Neoplasm MH - Extracellular Matrix Proteins MH - *Gene Amplification MH - Gene Dosage MH - Glypicans MH - Heparan Sulfate Proteoglycans/*genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Lymphoma/*genetics/metabolism/pathology MH - RNA, Messenger/analysis EDAT- 2003/05/02 05:00 MHDA- 2004/02/26 05:00 CRDT- 2003/05/02 05:00 PHST- 2003/02/14 00:00 [received] PHST- 2003/03/13 00:00 [accepted] PHST- 2003/05/02 05:00 [pubmed] PHST- 2004/02/26 05:00 [medline] PHST- 2003/05/02 05:00 [entrez] AID - 10.1007/s10038-003-0026-2 [pii] AID - 10.1007/s10038-003-0026-2 [doi] PST - ppublish SO - J Hum Genet. 2003;48(6):331-335. doi: 10.1007/s10038-003-0026-2. Epub 2003 Apr 29.